Media OutReach
VinFuture Prize empowered the woman scientist Dr. Firdausi Qadri to give back to Bangladesh

Sharing with the VinFuture Foundation, Dr. Qadri reflects on her groundbreaking work and her passion for expanding STEM education for women. In the face of societal barriers, particularly in Bangladesh, she remains committed to empowering women in science and using her VinFuture Prize value to strengthen the country’s scientific community.
The ongoing battle against cholera
Having established herself as one of the scientific titans in the vaccine area, Dr. Qadri has developed a single oral dose of an affordable cholera vaccine to address the public health needs in Bangladesh. Her research opens the possibility of large-scale vaccination campaigns in poor countries to prevent outbreaks and reduce the healthcare cost burden, allowing them to invest in education and economic activities. This revolutionizing discovery has earned her global recognition, including the 2024 VinFuture Special Prize for Innovators from Developing Countries.
“The VinFuture Prize was completely unexpected, but it has given me immense energy and a profound sense of purpose to turn scientific solutions into real-world applications that benefit those in adverse settings, including humanitarian crises globally,” Dr. Qadri said.
Beyond its personal significance, the VinFuture Prize also empowered Dr. Qadri to give back to her home country. In 2014, Dr. Qadri formed a non-profit research institution called the ideSHi (Institute for Developing Science and Health Initiatives) located on the 11th floor of Blue Moon Gram Tower in ECB Chattar, Dhaka. She shared an astounding initiative to expand this institute using the 500,000 USD prize value from VinFuture, “Together with the VinFuture Prize money and a quarter of my personal funds, I took a bold step forward, acquiring an additional 5,000 square feet of space within the same building as ideSHi’s original facility,” she elaborated.
This facility is a bold initiative dedicated to improving public health and nurturing the next generation of scientists. Since then, this institute provides state-of-the-art facilities, offers training programs, collaborates with international partners, conducts research on genetic diseases including thalassemia – the most common blood disorder in Bangladesh – as well as infectious diseases.
“Over the past decade, ideSHi has expanded tremendously, and this new extension will allow us to tackle even more critical health challenges while further strengthening scientific capacity in Bangladesh,” she shared. “With prize money received from VinFuture, I am confident that this support will help ideSHi develop pragmatic solutions to public health challenges and ultimately help advance Bangladesh’s position in biomedical research.”
The achievement results in her determination after witnessing firsthand the dire impact of cholera and diarrheal diseases. Her journey began as a scientist with a deep passion for immunology, later on extended her work beyond the laboratory to the field, fully devoted to the cause of uplifting the lives of Bangladesh and beyond.
However, through her extensive work in diarrheal diseases at their main hospital in Bangladesh, Dr. Qadri estimates an annual intake of approximately 200,000 patients, with 90-95% comes from impoverished backgrounds. Living in overcrowded conditions with shared toilets, kitchens, and bathrooms, they face rapid disease transmission. “If one person contracts cholera, the infection can spread to three other people in the family and beyond due to contaminated hands and food,” Dr. Qadri explained. “It’s very difficult to control.”
Recognizing the persistent devastation of global health crises, Dr. Qadri extended her research beyond the laboratory. She conducted field studies on vaccine effectiveness, distribution strategies, and public health interventions. Her efforts extended beyond academia as she worked more with the government, advocating for necessary actions to improve healthcare access.
“Over 15 to 20 years, my work has evolved to encompass not just vaccine development, but also implementation strategies – exploring the effectiveness of different modes in delivering vaccines and understanding how to integrate water, sanitation, and hygiene (WASH) with vaccination programs to achieve cholera control,” she noted.
Dr. Qadri emphasized that cholera remains a disease of poverty, often overlooked due to its association with inadequate sanitation and clean water access. She also pointed out that some governments were reluctant to acknowledge the disease’s prevalence, fearing for their global image. Therefore, she expressed deep gratitude and immense joy at being recognized by such a prestigious global award as the VinFuture Prize. “This recognition is a tremendous honor and serves as a motivation for me to move ahead,” she shared.
Breaking glass ceilings
Dr. Qadri’s dedication to rigorous scientific research and her success in the cholera vaccine area serves as an inspiration for young women all over the world. However, for women in science, particularly in developing countries across Asia, the road is often fraught with challenges. Deep-seated prejudices and invisible glass ceilings make it difficult for women to gain recognition in male-dominated fields.
“I always want to be known as a scientist, not a “woman scientist,” who works alongside men as equals“, Dr. Qadri shared. “But I cannot deny that acceptance has not always come easily.”
The unwavering support of her family played a crucial role, encouraging her to push boundaries and proving that a woman is just as capable as a man. “I traveled to remote areas, worked long hours in the field, and committed myself fully to scientific research. I have managed to overcome many prejudices, though challenges remain,” she noted.
It is also a driving force that motivates her to passionately advocate for empowering women in STEM education. According to her, science, technology, engineering, and mathematics are the foundation of progress, driving innovation and shaping the future. Yet, women remain underrepresented in STEM fields, not only in developing countries but even in advanced economies.
“If we truly want to make a meaningful contribution to the world, women must be part of this transformation,” Dr. Qadri emphasized.
Many hesitate to pursue careers in STEM, not due to a lack of ability but because of societal expectations and deeply ingrained biases. Fields including engineering and mathematics, in particular, remain male-dominated, with cultural norms dictating which professions are deemed “suitable” for women.
Another critical factor is the cost and commitment required. STEM education is more demanding, expensive, and time-intensive compared to fields including finance or commerce. Success in STEM requires years of dedication and persistence, making it an uphill battle, especially for women who must balance professional ambitions with societal expectations of family life.
“I try to use my journey to show young women that it is possible to have a family, raise children, and do science.” She remarked, “You just need to know the mechanism to do it. There is no secret formula: just focus, perseverance, and unwavering commitment to the work you choose to do.”
Addressing health disparities
Driven by the goal to seek effective preventive public health solutions for Bangladesh and other developing countries, Dr. Qadri focuses on large-scale clinical studies using Vietnamese live vaccine train, which allowed her to conclude the benefit, power and feasibility of an oral dose of an affordable vaccine.
“Vietnam, which has been able to control cholera better through concerted public health efforts, has always been an example I reflected on.” She stated, “If Vietnam can better control cholera through a comprehensive public health approach, why can’t we?”
Besides vaccination, the scientific titan emphasized the need for a holistic approach, including improvements in WASH education, and surveillance. However, behavioral change and access to clean water remain significant hurdles. Thus, according to Dr. Qadri, to provide crucial protection in the short term, there are two key strategies: reactive vaccination during an outbreak and preventive vaccination to build immunity.
However, a major obstacle the world faces is the global shortage of cholera vaccines. “Despite cholera affecting millions across Asia, Africa, and Latin America, only 80 million vaccine doses are currently available annually. This is far below what is needed – Bangladesh alone requires 100 million doses in the coming years,” she noted.
The economic constraints surrounding cholera vaccines also present a challenge. Since cholera is often considered a “disease of poverty,” many pharmaceutical companies hesitate to invest in its production due to low profit margins. “This is already happening,” she stressed.
To address this, Dr. Qadri actively advocates for increased vaccine production in Bangladesh. She shared that one of her team’s key achievements has been demonstrating that in a major outbreak, giving the vaccine in a reactive way can quickly reduce the number of cases. “We have implemented this strategy in multiple regions of Bangladesh,” Dr. Qadri added.
“More importantly, as a result of our dedication, we now have a national cholera control plan, centered on preventive vaccination, ensuring that people receive doses regularly – whether annually or every three years – to stay protected before outbreaks occur. This is a significant milestone in our fight against the disease.” she said.
Hashtag: #VinFuture
https://vinfutureprize.org/vinfuture-prize-nomination/
The issuer is solely responsible for the content of this announcement.
VinFuture
The VinFuture Foundation, established on International Human Solidarity Day on December 20th, 2020, is a non-profit organization co-founded by billionaire Mr. Pham Nhat Vuong and his wife, Mrs. Pham Thu Huong. The Foundation’s core activity is awarding the annual VinFuture Prize, which recognizes transformative scientific and technological innovations capable of making significant positive changes in the lives of millions of people worldwide.
The nomination period for the 2025 VinFuture Prize will close at 2:00 PM on April 17, 2025 (Vietnam time, GMT+7).
The VinFuture Prize consists of four prestigious awards presented each year. The most esteemed is the VinFuture Grand Prize, valued at US$3 million, making it one of the largest annual prizes globally. Additionally, there are three Special Prizes, each valued at US$500,000, specifically dedicated to honoring women innovators, innovators from developing countries, and innovators with outstanding achievements in emerging fields.
Media OutReach
“One Earth Summit” 2025 Held Successfully Hong Kong Fully Leverages Its Role as an International Financial Center and Leader in Green Finance
Laying a Solid Foundation for the Development of ESG Investment and Green Innovation
- Calling for Global Collaboration Among Governments, Businesses, and Philanthropic Organizations to Effectively Address Climate Change
- Over 300 Influential Leaders and Change-makers Gather in Hong Kong to Plan the Path Forward for a Sustainable Future
HONG KONG SAR – Media OutReach Newswire – 28 March 2025 – The “One Earth Summit,” hosted by the Institute of Sustainability and Technology and co-organized with the One Earth Alliance and the Giving to Amplify Earth Action (GAEA) initiative launched by the World Economic Forum, was held today at the Regala Skycity Hotel.
The theme of the forum was “Driving Systemic Change Towards a Sustainable Future through Impact Investment and Technological Innovation.” The event attracted over 300 influential leaders and change-makers from various sectors including finance, startups, foundations, media, civil society organizations, and academia from around the world, focusing on dialogue aimed at actionable solutions to respond to global population growth.
In his speech, Mr Paul Chan Mo-po, Financial Secretary, The Government of the Hong Kong Special Administrative Region stated, “As an international financial center and a leader in green finance, Hong Kong can help bridge the funding gap for green projects. Hong Kong’s issuance of green bonds has ranked first in the Asian market for seven consecutive years, with a market share reaching approximately 45% last year. At the same time, Hong Kong is seeking innovative financing solutions, such as tokenized green bonds and infrastructure financing securitization, to attract new investors. Hong Kong is committed to achieving carbon neutrality before 2050, focusing on three major strategies: zero-carbon power generation, green buildings, and sustainable transportation, as well as waste reduction. Global measures to tackle climate change create new business opportunities in burgeoning markets for green products and services. The budget announced earlier this month includes the establishment of a GreenTech Hub, which will accommodate 200 technology firms and serve as a nexus for public-private partnerships and international collaboration, with hopes that more private capital will drive green technology development and build a prosperous ecosystem. Additionally, artificial intelligence has widespread applications in sustainable development, emphasizing the government’s recognition of the significant potential of incorporating AI into the green ecosystem, designating it as a core industry.”
Professor Poman Lo, Chair of One Earth Summit Board of Advisory, Founder of Institute of Sustainability and Technology; Vice Chairman of Regal Hotels Group, remarked in her welcoming speech, “, We are a massive hub of human capital, talent, and innovation. Asia can surely play a pivotal role in leading the global net zero transition. One Earth Summit is part of the major transformation underway to bring Hong Kong closer to our ambition of being an international hub for sustainable finance and green innovation.”
Additionally, Mr Rob Van Riet, Senior Special Adviser to Managing Board, World Economic Forum, and Mrs Amy Lo, Chairman of UBS Global Wealth Management Asia, Head and Chief Executive, UBS Hong Kong, also delivered speeches on the future of sustainable technology and finance before the official start of the forum.
During the forum, speakers focused on three major topics, including:
- Buildings and Transportation: Exploring the future development of green buildings and smart transportation;
- Energy Transition: Sharing the latest technologies and investment opportunities in renewable energy and energy IoT;
- Food and Water Resources: Analyzing global strategies for sustainable management of food and water resources.
For more event information, please visit the forum’s website: www.oneearthsummit.org/
Hashtag: #InstituteofSustainabilityandTechnology #OneEarthSummit
The issuer is solely responsible for the content of this announcement.
Media OutReach
Diabetes Association Unveils T-CaReMe Taipei Declaration at the Asia Diabetes International Conference

In an effort to achieve a target of 80% of patients controlling the three highs and protecting kidney health within eight years, Taiwan leads the international trend of precise prevention with public-private collaboration in response to the new health goals of Healthy Taiwan.
TAIPEI, TAIWAN – Media OutReach Newswire – 28 March 2025 – As the global aging process accelerates, the prevention and care of chronic diseases have become a top priority for countries worldwide. The Taiwanese government has actively responded to international trends by promoting the “Healthy Taiwan” policy and launching the “Three Highs Prevention 888 Plan.” At the third “Healthy Taiwan Promotion Committee” meeting held last month, new goals were announced to reduce the standardized mortality rate of chronic diseases related to the three highs by one-third by 2030, aiming to strengthen chronic disease prevention and control measures through public-private collaboration. In alignment with the vision of “Healthy Taiwan” and the 888 Plan, and connecting with the international trend of “precision prevention” of chronic disease management, the Taiwan Diabetes Association formally presented the “T-CaReMe Precision Care Taipei Declaration” at the Asia Diabetes International Conference.
With a comprehensive national health insurance system in place, Taiwan ensures that every high-risk group can receive proactive prevention and personalized management early on, demonstrating international competitiveness in the accessibility and completeness of chronic disease care. To address the increasingly severe challenge of chronic diseases—particularly hypertension, hyperlipidemia, diabetes (the three highs), and chronic kidney disease—the Taiwan Diabetes Association unveiled the “T-CaReMe Precision Care Taipei Declaration” at the 17th Scientific Meeting of the Asian Association for the Study of Diabetes (AASD). This declaration was made in witness of various governmental agencies, academic institutions, and medical associations, including the Asian Association for the Study of Diabetes, the National Health Insurance Administration, the Health Promotion Administration, Academia Sinica, the National Health Research Institutes, the Taiwan Society of Nephrology, and the Taiwan Society of Cardiology. The declaration responds to the government’s vision of “Healthy Taiwan” and the goals of the 888 Plan, which focus on delaying disability and increasing life expectancy. It proposes a comprehensive health care model for chronic diseases centered around risk stratification, precision medicine, and digital management, further promoting the integration of holistic health care and medical services, while fostering interdisciplinary collaboration to drive a new paradigm of chronic disease prevention and treatment.

New Health Goals for Healthy Taiwan: Reduce Standardized Mortality Rate of Chronic Diseases Related to the Three Highs by One-Third
The Taiwan Diabetes Association Unveils T-CaReMe Declaration to Promote Precision Care Blueprint for Kidney Health in Relation to the Three Highs
With the trends of aging, prolonged illness, and the emergence of chronic diseases at younger ages, chronic disease prevention and management have become a global focus. Taiwan is following international trends by establishing the “Healthy Taiwan Promotion Committee,” which has set two major health goals for the next eight years: to increase the average life expectancy of the population from 79 to 82 years and to reduce the proportion of unhealthy life expectancy from 10% to 8%. To strengthen chronic disease management, the government recently announced a target at the Healthy Taiwan Promotion Committee meeting to “reduce the standardized mortality rate of chronic diseases related to the three highs by one-third by 2030,” along with comprehensive strategies promoting healthy lifestyles, obesity prevention, and holistic management of chronic diseases, through public-private collaboration to enhance health policies and reduce the risks of chronic diseases and disabilities.
The Taiwan Diabetes Association has released the “T-CaReMe Precision Care Taipei Declaration,” making “Kidney Protection in Relation to the Three Highs” a core focus. Through the T-CaReMe initiative, the vision of “risk stratification, precision medicine, digital management, and increased life expectancy” is implemented, along with five key action frameworks: promoting precise risk diagnostics, standardized clinical guidelines, personalized health management, data sharing, and interdisciplinary collaboration. The goal is to ensure that 80% of patients with the three highs and kidney disease achieve control of blood glucose, blood pressure, and blood lipids while ensuring that 80% of kidney disease patients receive care and medication guidance from care managers, thereby enhancing survival rates and improving health quality, creating a stronger defense for chronic disease care in the population.
Risk Stratification × Precision Medicine: T-CaReMe Initiative Launches a New Future for Chronic Disease Management
International Experts Gather to Establish Taiwan as a Demonstration Base for Chronic Disease Care
The T-CaReMe Taipei Declaration focuses on precise risk diagnostic classification and assessment, aiming to accurately identify high-risk populations and improve the effectiveness of chronic disease management. Through expert consensus and clinical risk stratification, as well as medical guidelines, the initiative integrates clinical data with international standards to ensure that patients receive personalized health management and appropriate treatment. Additionally, the declaration emphasizes collaboration across nations and disciplines, engaging in precision medicine and research achievements in the realm of chronic diseases in the Asia-Pacific region, influencing public health policies and improving chronic disease care outcomes, while developing a more precise and accessible holistic health care approach, solidifying Taiwan’s position as a regional demonstration base.
The meeting brought together experts and scholars from the National Health Insurance Administration, the Health Promotion Administration, Academia Sinica, and the National Health Research Institutes, along with representatives from the International Diabetes Federation (IDF-WPR) and the Asian Association for the Study of Diabetes (AASD), to witness the official launch of the “T-CaReMe Precision Care Taipei Declaration.” The Taiwan Diabetes Association stated that the declaration not only lays the groundwork for Taiwan’s development blueprint in precision chronic disease care and kidney health management related to the three highs but also aims to promote upgrades in chronic disease management models, enhance interdisciplinary collaboration, and build a more comprehensive health care system, driving improvements in global chronic disease care quality and prosperity starting from Taiwan.
Dr. Wu Mai-Su, President of the Taiwan Society of Nephrology, noted that although Taiwan has developed risk stratification and data-driven personalized treatment, standardized guidelines have yet to be incorporated, and clinical applications still have room for improvement, especially in the integrated management of kidney disease and diabetes. He expressed that through the T-CaReMe initiative, interdisciplinary collaboration can facilitate the integration of chronic kidney disease risk and comorbid management with diabetes and hypertension, contributing to higher patient survival rates and better kidney function maintenance. Dr. Li Yi-Heng, President of the Taiwan Society of Cardiology, emphasized that risk stratification and data-driven personalized management can effectively reduce the incidence of cardiovascular events, further strengthening the health defenses of the population. Dr. Hsu Hui-Heng, Deputy Director of the National Health Research Institutes, stated that the application of precision medicine will play a crucial role in future chronic disease management. The National Health Research Institutes is actively exploring several initiatives, such as using AI technology and big data to establish smart risk prediction systems, believing that under the visionary actions of the T-CaReMe initiative, there will be further optimization of precise predictions for cardiovascular, kidney, and metabolic disease risks, providing better scientific bases for the prevention of primary and secondary complications and organ damage associated with chronic diseases, thus realizing Taiwan’s health blueprint.
Aligning with International Standards! T-CaReMe Initiative Promotes a New Paradigm of Precision Chronic Disease Management
Taiwan will construct a comorbidity risk database within two years. The T-CaReMe initiative calls on all sectors to build a defense against chronic diseases.
In recent years, the Health Promotion Administration has actively promoted the “Scientific Disease Calculation Center” and risk prediction tools to enhance public health literacy and self-management awareness, delaying the onset of chronic diseases through proactive health education. Meanwhile, the National Health Insurance Administration has introduced AI risk stratification tools and a tiered care system, promoting the “Everyone’s Health Platform” and comprehensive, patient-centered care to improve care efficiency and resource utilization. Professor Chen Chih-Hong, Vice Convener of the Healthy Taiwan Promotion Committee, stated that the T-CaReMe initiative aligns closely with government policies integrating prevention and treatment, reflecting the core spirit advocated by the 888 Plan. In the future, it is hoped that all sectors will work together to deepen interdisciplinary collaboration and public-private integration, creating a sustainable and resilient model for chronic disease care.
The global healthcare community has identified precise risk assessment and personalized treatment as key trends in chronic disease management. The latest diabetes care guidelines particularly address the comorbidity risks associated with the three highs and kidney disease, suggesting earlier intervention in cardiovascular and kidney health management and enhancing data-driven diagnostic models. The importance of early screening and treatment is emphasized, and precise risk assessment and integration of patient data will be core development directions for future chronic disease management. These international trends indicate that global chronic disease management is moving towards precision medicine, digital monitoring, and interdisciplinary integration, which aligns closely with the goals of the T-CaReMe initiative.
The Taiwan Diabetes Association took action as early as 2023, collaborating with 12 medical institutions in Taiwan to join the iCaReMe global registry program. Through interdisciplinary integrated care, patient tracking, and the application of clinical data, it not only provides more precise risk assessments and patient profiles but also effectively monitors and optimizes treatment outcomes, which has been shown to improve patients’ health conditions. Chairman Huang Jian-Ning shared that the short-term goal of the T-CaReMe initiative is to construct a representative database within two years. By analyzing lifestyle factors, it aims to more accurately assess the comorbidity risks of different patients. Implementing a comprehensive model for precision chronic disease care requires not only efforts from the medical community but also active participation from government agencies, academic institutions, industry partners, and civic groups to jointly promote data integration and personalized health management, ensuring that risk stratification and standardized guidelines are continually refined, while enhancing chronic disease management effectiveness in Taiwan and the Asia-Pacific region.
Yutaka Seino, Chair of the Asian Association for the Study of Diabetes conference, stated that Taiwan has consistently been at the forefront of chronic disease prevention and treatment in Asia, and he hopes that through public-private collaboration and interdisciplinary cooperation, Taiwan can lead the global improvement of chronic disease care quality.
Hashtag: #DiabetesAssociation
The issuer is solely responsible for the content of this announcement.
Media OutReach
Li Ning Company Limited Announces 2024 Annual Results
Strengthen the “Single Brand, Multi-Categories, Diversified Channels” Strategy | Solidify Brand and Product Competitiveness, Ensure Steady Operations, and Achieve Pragmatic Growth
HONG KONG SAR – Media OutReach Newswire – 28 March 2025 – Li Ning Company Limited (the “Company” or “Li Ning Company”; together with the subsidiaries, collectively, the “Group”; stock codes: 2331 (HKD counter) and 82331 (RMB counter)) announces today its 2024 annual results for the year ended 31 December 2024 (the “Year”).
Financial Results
In 2024, the Group’s annual performance was generally in line with expectations, a result of robust operational resilience and effective strategic execution. During the Year, the Group’s revenue amounted to RMB28,676 million, representing an increase of 3.9% as compared to that of 2023 (2023: RMB27,598 million). Gross profit amounted to RMB14,156 million, representing an increase of 6.0% compared to that of 2023(2023: RMB13,352 million). The overall gross profit margin increased by one percentage point to 49.4%(2023: 48.4%).
During the year, the net profit attributable to equity holders was RMB3,013 million (2023: RMB3,187 million). The margin of net profit attributable to equity holders was 10.5% (2023: 11.5%). Return on equity attributable to equity holders was 11.9% (2023: 13.1%). Basic earnings per share was RMB116.98 cents (2023: RMB123.21 cents). The Board has recommended the payment of final dividend of RMB20.73 cents per ordinary share for the year ended 31 December 2024, together with the interim dividend of RMB37.75 cents per ordinary share paid in September 2024, the total dividend for the year ended 31 December 2024 will amount to RMB58.48 cents per ordinary share or a total dividend payout ratio of 50%(2023: 45%).
In terms of cash flow management, the Group’s net cash generated from operating activities during the year amounted to RMB5,268 million (2023: RMB4,688 million). As at 31 December 2024, cash and cash equivalents (including cash at banks and in hand, and fixed term deposits with original maturity of no more than three months) amounted to RMB7,499 million, representing an increase of RMB2,055 million, as compared with the position as at 31 December 2023. Adding back the amount recorded as fixed-term deposits held at banks, cash balance amounted to RMB18,141 million, which represented a net increase of RMB166 million as compared to 31 December 2023. During the year, the Group maintained a healthy level of operating capital, and the net cash generated from operating activities increased compared to the previous year. The Company will continue to prudently assess its capital plan in light of market conditions and capital requirements to ensure maximum efficiency in the use of capital and to support its long-term development objectives.
Operational Summary
During the Year, the Group maintained its focus on the core strategy of “Single Brand, Multi-categories, Diversified Channels” to enhance product strength through continuous research and development and technological innovation. Furthermore, the Group made significant progress across various aspects of its business including product innovation, brand building, and channel optimization.
In 2024, the Group made multi-dimensional breakthroughs in the research and development of technologies. During the Year, the Group launched the new midsole technology “Super BOOM”(超䨻), which is not only lighter and more elastic but also boasts an exceptional elasticity-to-weight ratio, representing the pinnacle of performance for supercritical foaming materials. The BOOM technology platform has achieved four application breakthroughs within six years, evolving from a “single technology” to “four major technologies”. This progression demonstrates the Group’s commitment to exploring materials and manufacturing processes and exceptional ability to deploy and broaden their application, further enhancing its ability to diversify product offerings and iterate product lines.
In respect of branding and marketing, the Group continued to focus on the six core categories of running, basketball, training, badminton, table tennis, and sports casual. It also actively explored emerging sports and subcategories, such as outdoor sports, golf, tennis and pickleball. The Group leveraged technological innovation capabilities to drive product upgrades underpinned by three key pillars: solidifying a professional sports mindset, showcasing sports fashion aesthetics, and inheriting Chinese cultural values. Moreover, it proactively sought to strengthen its differentiated brand advantages and enhance brand influence through diversified and comprehensive marketing campaigns. Capitalizing on the market opportunities presented by a year distinguished major sporting events, the Group delved into the essence of its brand spirit and gained insights into the younger generation’s attitudes towards sports. Through these efforts, it articulated the brand spirit of “Dare to Imagine, Create Excellence, Anything is Possible”(敢於想像,創造精彩,一切皆有可能) and launched the “In My Name”(以我為名)-themed marketing campaign, aiming to solidify LI-NING’s professional image and establish a deeper emotional connection with consumers.
In respect of channel, the Group consolidated and enhanced operational efficiency for high-end markets and accelerate expansion into emerging markets. In the high-end markets, the Group focused on improving the efficiency of single store sales through a series of refined management processes and the orderly closure of stores with substantial losses to make the channel layout more reasonable, effectively enhancing overall channel efficiency. At the same time, the Group actively expanded its presence in emerging markets. Diversified sales strategies and flexible market response capabilities enable the Group to gradually expand its market share in emerging markets. As of 31 December 2024, the number of conventional stores, flagship stores, China LI-NING stores, factory outlets and multi-brand stores under the LI-NING brand (including LI-NING Core Brand and LI-NING YOUNG) amounted to 7,585, representing a net decrease of 83 POS as compared to 31 December 2023. The number of distributors was 41 (including sales channels of China LI-NING stores), representing a net decrease of 5 as compared to 31 December 2023.
In terms of retail operations, the Group intensified efforts to promote a single-store operational model with solid profit and efficiency. It established standard profit and loss models for stores at all levels, standardizing and quantifying core store metrics to link them with management objectives across departments. This formed an efficient and coordinated management system, contributing to improved overall operational efficiency. The Group also strengthened the synergies between inventory and sales planning for single-stores and was committed to achieving improvements in both operational efficiency and supply chain management, ensuring efficient and accurate resource allocation and profitability.
In terms of new retail business, the Group continued to deepen the construction of its new retail business system, focusing on enhancing digitalization and all-channel operational capabilities. The aim is to efficiently convert private traffic and steadily improve sales performance. The Group actively explored diversified business models such as acquiring traffic through popular social media platforms like Douyin (抖音) and collaborating online with core channels to broaden sales, increase the proportion of out-of-store sales, and empower stores with new retail capabilities.
In terms of e-commerce operations, facing intensified market competition and a sluggish consumption environment, the Group continued to deepen e-commerce reform and strengthened its core competitiveness in the e-commerce sector across the board through online and offline interaction, diversified marketing campaigns, and precise capture of major sales promotions.
In terms of supply chain, the Group focused on exploring and matching high-quality supply chain resources, gradually improving the supplier matrix for high-end and outdoor products to ensure precise alignment between products and supply chain resources. The Group also implemented a flexible supply chain strategy to closely monitor market demand. Initiatives to refine management and analyse digital information support interoperability and transparency, improve the level of automation, and significantly enhance inventory efficiency along the supply chain. While flexibly responding to market changes, the Group strived to achieve dual improvements in production efficiency and economic benefits.
In 2024, the Group made remarkable achievements in logistics. Four major regional logistics centres across the country underwent comprehensive automation upgrades and began operations. The Nanning central warehouse is set to begin operations in 2025, which will improve delivery efficiency and logistics and warehousing operational capabilities in the southwest of the country. The Group is also proactively promoting refined logistics plan management across its divisions. Through the optimization of digital tools, the Group catered to the specific needs of its sales teams, improved the efficiency of goods distribution, and reduced logistics costs.
In terms of kidswear business, LI-NING YOUNG refined its youth product offerings, leveraging the core competitiveness of its clothing and accessories, while actively expanded into emerging markets, improved single-store efficiency, strengthened construction of clearance channels, promoted product distribution, and expanded the customer base. In terms of retail operations, LI-NING YOUNG continued to enhance operational efficiency and actively acquire and convert customers. Meanwhile, the Group actively built a community marketing system to strengthen member interaction and provide exclusive benefits to strengthen member loyalty and sales conversion rates. In terms of marketing, LI-NING YOUNG planned a series of offline youth activities and cross-border collaborations, focusing on popular sports including basketball, football, running and outdoor activities to showcase the brand’s diverse appeal. Meanwhile, LI-NING YOUNG leveraged social media platforms, ensuring that its messaging reaches target audiences, drives engagement, and reinforces the concept of being a “professional youth sports brand”. As at 31 December 2024, the total number of LI-NING YOUNG POS amounted to 1,468, representing a net increase of 40 POS since 31 December 2023.
Outlook
Looking ahead, the Group will continue to fulfil its commitments by focusing on its core strategy of “Single Brand, Multi-categories, Diversified Channels”, and ensure its effective implementation by strengthening operational systems and consolidating foundational support.
1. Strengthen the implementation of core strategies. By maintaining the healthy development of its core businesses, the Group will further integrate resources and leverage the LI-NING technology platform to further improve its professional product offerings in subcategories such as running, basketball, training, badminton, table tennis and sports casual. It will also deepen the fusion of the sporting spirit and its brand to enhance its competitiveness and influence in core business areas. Meanwhile, in addition to active efforts to optimize its product structure, the Group will expand diversified dressing scenarios with a commitment to the single-brand strategy, deeply integrate sports fashion culture, and launch sports products that combine technology and fashion. In addition, it will take the lead in laying out new pathways for sports consumption, especially in the markets for women, outdoor and youth, striving to achieve breakthrough progress in these emerging fields and drive diversified business expansion. Moreover, the Group is committed to expanding its presence in all target markets, with the aim to create business opportunities in each channel, continuously enhance brand influence, and drive sustained business growth.
2. Optimize operational efficiency. The Group will focus on boosting operational efficiency to ensure the effective implementation of its “Single Brand, Multi-categories, Diversified Channels” strategy. Deepened cross-departmental collaboration and streamlined business processes will empower the Group with efficient product management operations and allchannel integration and supply chain collaboration. Meanwhile, the Group will adopt refined management practices and strictly control costs and benefits, to ensure optimal allocation of resources. At the organizational level, the Group will endeavour to streamline management levels, optimize talent structure, cultivate efficient teams, and promote collaboration among organizations, in order to accelerate the decision-making process, enhance execution, and build a flexible and efficient operational structure.
3. Reinforce underlying support. In terms of underlying support, the Group will ensure sound operations of its financial systems, strengthen fund management and optimize capital structure, and improve financial transparency in a way that provides a solid financial foundation for long-term development. At the same time, the Group will deepen the integration of digital and smart tools by applying digital and intelligent technologies to make more scientific business decisions and adapt with agility to market changes. Through data analysis, artificial intelligence and automation tools, the Group will enhance its insight into market trends and understanding of consumer behaviour, thereby driving innovation in products and services and providing strong support for sustained development.
Mr. Li Ning, Executive Chairman and Joint CEO of the Group, concluded, “Looking ahead to 2025, with strong policy support, consumer spending has the potential to grow decently in China. As a company with long-term roots in China market and a focus on professional products for sports, we are confident in our future development and will seize this opportunity to drive high-quality growth.
Notably, LI-NING will once again partner with the Chinese Olympic Committee and the Chinese Sports Delegation from 2025 to 2028, which underscores the full trust and responsibility bestowed by the General Administration of Sport of China and the Chinese Olympic Committee and the high recognition of the Group’s professionalism and innovation. By adhering to its core value of ‘serving the public with sportsmanship’, LI-NING is committed to becoming the most prominent and stylish sports brand from China and the preferred sports brand of Chinese consumers.”
Hashtag: #LiNing #Sportswear
The issuer is solely responsible for the content of this announcement.
About Li Ning Company Limited
Li Ning Company Limited is one of the leading sports brand companies in China, mainly operating professional and leisure footwear, apparel, equipment and accessories under the LI-NING brand. The Group has comprehensive research and development, design, manufacturing, marketing, distribution and retail management capabilities. It has established an extensive retail distribution network and supply chain management system in China. We are committed to be the most prominent, stylish, world-leading sports brand from China.
In addition to its core LI-NING brand, the Group also manufactures, develops, markets, distributes, sells various sports products which are self-owned by or licensed to the Group, including Double Happiness (table tennis), AIGLE (outdoor sports) and Kason (badminton), which are operated through joint venture/associate with third parties of the Group.
-
Feature/OPED5 years ago
Davos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz2 years ago
Estranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years ago
Sort Codes of GTBank Branches in Nigeria
-
Economy2 years ago
Subsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking2 years ago
First Bank Announces Planned Downtime
-
Sports2 years ago
Highest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn
-
Technology4 years ago
How To Link Your MTN, Airtel, Glo, 9mobile Lines to NIN